Search

everythinglearnresearchcommunity

for

Search:↓

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Genes and hormones cause hair loss, with four genes contributing equally.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Men with a family history of hair loss are more likely to experience it themselves, especially if both parents have hair loss.

Minoxidil doesn't increase pericardial disorder risk, but may cause fluid accumulation.

Cardiovascular disease deaths decreased but still caused one-third of U.S. deaths in 2007, with high rates of hypertension, smoking, obesity, and diabetes.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

The study explains how minoxidil sulfate causes vasodilation in rabbits by opening potassium channels and inhibiting calcium channels.

Genes play a significant role in male-pattern baldness, and understanding them could lead to new treatments and insights into related health issues.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Trichoscopy is a non-invasive way to diagnose hair and scalp problems without needing hair samples.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

Using steroids can increase the risk of heart problems.

Higher BMI links to worse hair loss in Taiwanese men.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.